Two Seas Capital’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
Two Seas Capital's ROIV Position: Q3 2026 in Review
Two Seas Capital reduced its Roivant Sciences (ROIV) stake by 14% in Q3 2026, selling an estimated $41.7M and leaving 7,325,356 shares worth $268M. The position accounts for 3.09% of the portfolio, ranked #5.
Two Seas Capital first reported a position in ROIV in Q4 2021 and has held it in 20 quarters since. The position peaked at $300M in Q2 2026. 55 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- Two Seas Capital held 7,325,356 shares of Roivant Sciences worth $268M as of Q3 2026.
- Two Seas Capital sold 1,150,000 Roivant Sciences shares in Q3 2026, an estimated $41.7M.
- Roivant Sciences made up 3.09% of Two Seas Capital's portfolio in Q3 2026, its #5 holding.
- Two Seas Capital first reported a position in Roivant Sciences in Q4 2021 and has held it in 20 quarters since.
- Two Seas Capital's Roivant Sciences position peaked at $300M in Q2 2026.
- 55 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on Two Seas Capital's 13F filing for Q3 2026, filed 6 Oct 2026.